Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Other Liabilities
Abbott Laboratories
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Other Liabilities
$6.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Liabilities
$894m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Liabilities
$2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Liabilities
$851.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
24%
|
|
Stryker Corp
NYSE:SYK
|
Other Liabilities
$2.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Liabilities
$385.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
19%
|
See Also
What is Abbott Laboratories's Other Liabilities?
Other Liabilities
6.9B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Other Liabilities amounts to 6.9B USD.
What is Abbott Laboratories's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
5%
Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Abbott Laboratories have been -9% over the past three years , -3% over the past five years , and 5% over the past ten years .